A Week in Health: Lawsuits, Bold Moves, and Breakthroughs
Published on: March 22, 2026, 6:28 p.m. | Source: Devdiscourse
The health sector witnessed a flurry of activity with EyePoint suing Ocular Therapeutix over misleading claims. Spire continues sale talks, Prestige Consumer Healthcare acquires Breathe Right, and FDA gives green light to a new cancer treatment. UK addresses a meningitis outbreak, while Rhythm's groundbreaking therapy wins FDA approval.
